Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8835612 | 0.88 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL29450819 | 0.87 | PDE2A (0.55) | PDE2ALMNASMN1; SMN2CYP1A2ALDH1A1 | |
| SCHEMBL7052100 | 0.87 | PDE2A (0.55) | PDE2ALMNASMN1; SMN2CYP1A2ALDH1A1 | |
| SCHEMBL25622911 | 0.85 | PDE2A (0.53) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL12701526 | 0.84 | PDE2A (0.48) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL9912008 | 0.83 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL30318701 | 0.83 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL10241852 | 0.83 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL8198679 | 0.83 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 | |
| SCHEMBL11744262 | 0.83 | PDE2A (0.52) | PDE2ALMNASMN1; SMN2L3MBTL1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2725022-B1 | New amides as pest control agents | BAYER CROPSCIENCE AG (DE) | 2017-03-29 | — | — | EP | claimed |
| EP-2488510-B1 | Amides and thioamides as pest control agents | BAYER IP GMBH (DE) | 2017-03-29 | — | — | EP | claimed |
| EP-2350090-B1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC (CA) | 2015-06-03 | — | — | EP | claimed |
| EP-2297130-B1 | NEW HETEROAROMATIC AMIDES AND THIOAMIDES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG (DE) | 2014-09-17 | — | — | EP | claimed |
| US-8536204-B2 | Amides and thioamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2013-09-17 | — | — | US | claimed |
| US-8263606-B2 | Spiro-oxindole compounds and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2012-09-11 | — | — | US | claimed |
| EP-2410854-A2 | SUBSTITUTED 1, 4-DIOXA-8-AZASPIRO Ý4,5¨DECANES USEFUL AS FUNGICIDES AND A PROCESS FOR THE PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2012-02-01 | — | — | EP | claimed |
| EP-2350090-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | Xenon Pharmaceuticals Inc. (CA) | 2011-08-03 | — | — | EP | claimed |
| WO-2010109299-A2 | SUBSTITUTED 1, 4-DIOXA-8-AZASPIRO [4,5] DECANES USEFUL AS FUNGICIDES AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-30 | — | — | WO | claimed |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2010-06-03 | — | — | US | claimed |
| WO-2010045251-A2 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS, INC. (CA) | 2010-04-22 | — | — | WO | claimed |
| WO-2025076284-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | DELPHIA THERAPEUTICS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |
| US-11912708-B2 | Macrocyclic heterocycles and uses thereof | KUMQUAT BIOSCIENCES INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912708-B2 | Macrocyclic heterocycles and uses thereof | KUMQUAT BIOSCIENCES INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230382907-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ENLIVEN INC. | 2023-11-30 | — | — | US | disclosed |
| US-5276152-A | Process for the production of 4,6-dialkoxypyrimidines | LONZA LTD. (CH) | 1994-01-04 | — | — | US | disclosed |
| CN-1075715-A | 4, the production method of 6-dialkoxy pyrimidine | LONZA AG (CH) | 1993-09-01 | — | — | CN | disclosed |
| EP-0552759-A1 | Process for preparation of 4,6-dialkoxypyrimidines | LONZA AG (CH) | 1993-07-28 | — | — | EP | disclosed |
| EP-0539427-A1 | PYRIMIDINYL AND TRIAZINYL HERBICIDES | AgrEvo UK Limited (GB) | 1993-05-05 | — | — | EP | disclosed |
| WO-1992001677-A1 | PYRIMIDINYL AND TRIAZINYL HERBICIDES | SCHERING AGROCHEMICALS LIMITED (GB) | 1992-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912708-B2 | Macrocyclic heterocycles and uses thereof | HRAS, KRAS, TP53 | PDE2A 3207/4885LMNA 2455/4885SMN1; SMN2 1539/4885 |
| US-20230382907-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ABL1, ABL2, BCR | PDE2A 897/4885LMNA 3763/4885SMN1; SMN2 3904/4885 |
| US-20100137299-A1 | SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | TRPV3, TRPV1, TRPC3 | PDE2A 2185/4885LMNA 1296/4885SMN1; SMN2 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.